Trevena to Report Fourth Quarter and Full Year 2019 Results on March 12, 2020 Mar 05, 2020 5:00pm EST
Trevena Appoints Scott Applebaum as Chief Legal and Compliance Officer and SVP of Regulatory Affairs Feb 13, 2020 7:00am EST
Trevena Announces Initiation of Proof-of-Concept Study for TRV734 for Potential Treatment of Opioid Use Disorder Dec 23, 2019 7:00am EST
Trevena Presents Phase 1 Data on TRV250 for Acute Migraine at American College of Neuropsychopharmacology 2019 Annual Meeting Dec 12, 2019 7:00am EST
Trevena Announces Publication of Results from Special Population Studies for Oliceridine Nov 20, 2019 7:00am EST
Trevena Announces Publication of Results from Phase 3 “Real World” Safety Study for Oliceridine in The Journal of Pain Research Nov 20, 2019 7:00am EST
